GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,818,869 | +43.6% | 8,187,883 | +106.9% | 1.05% | +58.5% |
| Q2 2023 | $4,749,683 | +92.5% | 3,958,069 | +102.1% | 0.66% | +86.2% |
| Q1 2023 | $2,467,167 | -41.9% | 1,958,069 | 0.0% | 0.36% | -46.4% |
| Q4 2022 | $4,249,010 | -82.7% | 1,958,069 | -4.3% | 0.66% | -84.3% |
| Q3 2022 | $24,504,000 | +6.1% | 2,045,442 | -25.8% | 4.23% | -31.4% |
| Q2 2022 | $23,085,000 | +3.8% | 2,758,069 | +7.6% | 6.16% | +28.1% |
| Q1 2022 | $22,248,000 | +30.0% | 2,563,138 | +69.4% | 4.81% | +44.4% |
| Q4 2021 | $17,114,000 | -10.0% | 1,513,138 | 0.0% | 3.33% | -28.9% |
| Q3 2021 | $19,020,000 | +65.8% | 1,513,138 | +7.1% | 4.68% | +97.0% |
| Q2 2021 | $11,475,000 | -12.2% | 1,413,138 | 0.0% | 2.38% | -51.7% |
| Q1 2021 | $13,072,000 | -13.5% | 1,413,138 | -9.6% | 4.92% | -6.0% |
| Q4 2020 | $15,116,000 | – | 1,563,138 | – | 5.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |